ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,902.94
-1.30%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) 뉴스

AMGN Amgen Inc

269.98
0.60 (0.22%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Amgen Inc AMGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.60 0.22% 269.98 09:00:00
개장가 저가 고가 종가 전일 종가
265.72 265.72 271.68 269.98 269.38
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/04/202422:00PRNUSAMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION..
17/04/202406:26PRNUSAMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
10/03/202402:20PRNUSAMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD..
09/03/202407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:00PRNUSAMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
01/03/202406:00PRNUSAMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE..
26/02/202423:00PRNUSAMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN..
20/02/202406:00PRNUSAMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
15/02/202406:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
13/02/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:00PRNUSAMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE..
07/02/202419:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
07/02/202407:05IHMARKETNEWSU.S. Stocks Finish Choppy Trading Day Modestly Higher
07/02/202406:20EDGAR2Form 8-K - Current report
07/02/202406:01PRNUSAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL..
06/02/202420:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
03/02/202406:25IHMARKETNEWSU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon..
02/02/202406:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR..
29/01/202419:00PRNCAdeCODE genetics: A sequence variant that increases risk of..
17/01/202420:33IHMARKETNEWSWall Street Highlights: Tesla Cuts Prices in Germany,..
11/01/202400:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
10/01/202422:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
10/01/202422:45IHNWGLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
04/01/202406:00PRNUSAMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE..
03/01/202401:42DJNAmgen On Pace for Record High Close -- Data Talk
26/12/202323:00PRNUSAMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS®..
20/12/202310:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202323:53DJNAmgen Names James Bradner Chief Scientific Officer
14/12/202323:16EDGAR2Form 8-K - Current report
14/12/202323:00PRNUSAMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE..
14/12/202319:00PRNUSAMGEN TO SPONSOR THE IRISH OPEN
14/12/202306:40DJNAmgen Gets FDA Priority Review For Lung Cancer Treatment
14/12/202306:00PRNUSFDA Grants Priority Review to Amgen's Tarlatamab Application..
13/12/202320:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
13/12/202306:41DJNAmgen Raises Dividend 5.6% To $2.25 A Share
13/12/202306:00PRNUSAMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO..
08/12/202323:00PRNUSAMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
05/12/202309:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202309:40EDGAR2Form 144 - Report of proposed sale of securities
30/11/202310:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202306:00PRNUSAMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE

최근 히스토리

NASDAQ
AMGN
Amgen
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유